Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor
Not yet recruiting · NCT07041203 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, laryngeal disorder, nervous system disorder, otorhinolaryngologic disease, respiratory system disorder, spasmodic dystonia, voice disorders | Not yet recruiting | Phase 1 | 2026-04-28 | NCT07041203 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kristina Simonyan | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts Eye and Ear | Boston | United States | 21 |